Home » PrePub Compounds » LH1299
LH1299
M Wt. 266
Formula: C16 H14 N2 S
Smiles:
Phenotype
Descriptor
Anatomical Features AR1299
Axis | Reduced length |
Blood | Present |
Blood circulation | Absent, pooling |
Brain | Abnormal |
Cloaca | Absent |
Eye | Reduced size |
Eye pigmentation | Reduced amount |
Forebrain | Reduced size |
Fourth ventricle | Normal |
Head | Reduced size |
Heart | Abnormal, reduced size |
Heart contraction | Abnormal |
Locomotion | Reduced amount |
Melanocyte | Reduced amount |
Midbrain hindbrain boundary | Present |
Notochord | Reduced width, reduced length |
Otic placode | Reduced size |
Otolith | Normal |
Pericardium | Swollen |
Post-vent region | Absent |
Somite | Abnormal |
Third Ventricle | Reduced size |
Trunk | Reduced length |
Tail | Absent |
Whole organism | Reduced length |
Yolk | Increased size |
Cheminformatics
Molinspiration
Bioactivity score v2016.03
GPCR ligand -0.14
Ion channel modulator -0.06
Kinase inhibitor 0.11
Nuclear receptor ligand -0.22
Protease inhibitor -0.31
Enzyme inhibitor 0.05
ChemProt TC>0.97
N/A
Lasso
Category | Target | PDB Code | LASSO Score |
---|---|---|---|
Kinases | P38 MAP, P38 mitogen activated protein | 1kv2 | 0.94 |
Kinases | VEGFr2, vascular endothelial growth factor receptor | 1vr2 | 0.85 |
Kinases | PDGFrb, platelet derived growth factor receptor kinase | N/A | 0.71 |
Confirmed Pathway Activity
Synergist
Wnt signaling (EC2X): Does not potentiate